Credit Suisse Downgrades Sucampo Pharmaceuticals To Underperform By: Benzinga via Benzinga March 02, 2015 at 08:15 AM EST Analysts at Credit Suisse downgraded Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) from Neutral to Underperform. The price target for ... Read More >>